Divestiture

Consumers overcharged for generic drugs may get cash from a new $17.8M settlement. Find out if you're eligible and how this fits into a larger legal war.

Two Toledo auto shop sales highlight why investors are flocking to necessity-based real estate, driven by stable income and powerful tax incentives.

In a major strategic move, HSBC appoints Cécile Ratcliffe as CEO of its Continental Europe arm to drive growth in corporate and institutional banking.

Princess Padmaja Kumari Parmar receives the Mary Tyler Moore Award for her advocacy, bridging a legacy of hope with a modern fight for global T1D equity.

After a year of major restructuring and a new CEO, Innovative Food Holdings' upcoming earnings call will reveal if its new strategy is paying off.

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

With promising clinical data for its lead drug silevertinib and a strong new financial position, Black Diamond Therapeutics charts a dual course for two deadly cancers.

Graduates from South University's nursing programs are posting near-perfect exam scores, but how do these results fit into the school's complex history?

Banqup completes its divestment to Fitek Oü, pivoting from legacy assets to high-growth SaaS ahead of Europe's sweeping e-invoicing mandates.

Swiss lab-tech firm Tecan posts a major loss after strategic write-downs but launches an ambitious 'Rewired' plan to chase a CHF 1B sales target.

The kathy ireland Worldwide brand is in crisis as its founder files a $100M lawsuit alleging decades of fraud by her managers, fracturing the empire.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

A landmark housing bill meant to ease affordability faces fierce opposition for a new rule that could stifle rental construction and drive up costs.

Seanergy Maritime invests in modern Japanese newbuilds and sheds older tonnage, executing a complex strategy to dominate a tightening dry bulk market.

Theriva Biologics pushes its promising cancer virus toward pivotal trials, but an auditor's 'going concern' warning raises questions about its future.

Honda scraps key EV models and forecasts its first annual loss since 1977, signaling a massive industry pivot from electric dreams to hybrid reality.

With all regulatory approvals secured, the merger of FirstSun and First Foundation is set to close, creating a new force in regional banking.

Spire Global's appointment of John Martinez signals an aggressive strategy to expand its 'sovereign-ready' space intelligence for government clients.

The Personalized Health Association launches to modernize U.S. policy, sparking debate over innovation, patient safety, and the future of tailored care.